Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2022-03-25 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number' and references 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific, non-financial regulatory market event notification. This type of short, specific regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as per the definition of RNS being a fallback for miscellaneous filings that do not neatly fit elsewhere, although it is a specific type of RNS announcement.
2022-03-25 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 9429F' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational update related to trading mechanisms, not a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a specific, non-standard regulatory announcement distributed via the RNS system, and it doesn't fit into the other specific categories (like DIV, DIRS, or ER), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2022-03-24 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 chars) and contains the header 'RNS Number : 6567F'. It discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or DLST), the most appropriate classification is the general regulatory fallback category.
2022-03-22 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 6553F'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This is a general regulatory announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Therefore, it falls best under the general Regulatory Filings category.
2022-03-22 English
PALOH study results published in JAMA Pediatrics
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 4871F' and contains standard regulatory boilerplate language at the end, including 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a regulatory announcement disseminated via the RNS system. The content itself is an announcement about the publication of study results in a medical journal ('PALOH study results published in JAMA Pediatrics'). Since the document is an announcement of an external publication/event rather than the full report itself (and it is not a standard SEC filing like 10-K or ER), and it is clearly an RNS release, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements.
2022-03-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 characters) and contains the header 'RNS Number : 4313F' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory announcement concerning market operations. Since it is a direct, short announcement from the RNS system about a trading event rather than a comprehensive report (like 10-K or IR) or a standard corporate action (like DIV or ER), it fits best under the general regulatory announcement category, RNS, which serves as a fallback for miscellaneous regulatory filings.
2022-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.